• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD RESPIRATORY VIRAL PANEL FOR BD MAX¿ SYSTEM; MULTIPLE-GENUS RESPIRATORY VIRUS NUCLEIC ACID IVD, KIT, NUCLEIC ACID TECHNIQUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD RESPIRATORY VIRAL PANEL FOR BD MAX¿ SYSTEM; MULTIPLE-GENUS RESPIRATORY VIRUS NUCLEIC ACID IVD, KIT, NUCLEIC ACID TECHNIQUE Back to Search Results
Catalog Number 445373
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/05/2024
Event Type  malfunction  
Event Description
Report 2 of 6: it was reported that during use of the bd respiratory viral panel for bd max¿ system, there were false positives.When repeated using another platform (quidel (flu and rsv) or biorad (covid), the results do not match.(b)(6) positive for flu a, covid, and rsv.Repeated result was only positive for flu a and covid.There was no report of patient impact.
 
Manufacturer Narrative
H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
Report 2 of 6: it was reported that during use of the bd respiratory viral panel for bd max¿ system, there were false positives.When repeated using another platform (quidel (flu and rsv) or biorad (covid), the results do not match.Run 2113 - a5, positive for flu a, covid, and rsv.Repeated result was only positive for flu a and covid.There was no report of patient impact.
 
Manufacturer Narrative
H.6.Investigation summary: the complaint investigation for discrepant results when using the bd max¿ respiratory viral panel assay (ref.(b)(4) from lot 3237371 was performed by the review of manufacturing records, review of customer¿s data and by the complaint¿s history review.Customer complained about six positive results when using the bd max¿ respiratory viral panel kit lot 3237371 that could not be reproduced using quidel (flu and rsv) or biorad (covid) platforms.Review of the manufacturing records of bd max¿ respiratory viral panel assay indicated that lot 3237371 was manufactured according to specifications and met performance requirements.Customer provided sample runs 2111, 2113 and environmental run 2116 from instrument ct1490 that were analyzed.Manual pcr curve adjudication was conducted across samples identified by the costumer found in run 2111; position a3 and run 2113; position a5, b1, b2, b3 and b5.All gave a low but true amplification.Manual curve adjudication has limitations; visual examination of pcr curves for low signal is a conservative assessment of the data.Environmental run (run 2116) showed that 5 samples were tested and one of them gave a cov-2 positive result, suggesting environmental contamination at the customer site.The root cause was not identified.Based on the data and information provided, specimens at or near the assay limit of detection (lod), or environmental or cross contamination, are the most likely causes to explain the customer¿s positive results.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on the bd max¿ respiratory viral panel assay lot 3237371.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action since no new hazard or trends was identified.Bd quality will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD RESPIRATORY VIRAL PANEL FOR BD MAX¿ SYSTEM
Type of Device
MULTIPLE-GENUS RESPIRATORY VIRUS NUCLEIC ACID IVD, KIT, NUCLEIC ACID TECHNIQUE
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18782775
MDR Text Key336313613
Report Number3007420875-2024-00012
Device Sequence Number1
Product Code QOF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K230956
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number445373
Device Lot Number3237371
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/25/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-